Journal of Informed Pharmacotherapy 2002;8 (Jan-Mar)

Editorial

Pharmacist Scope of Practice: A Response to the 2002 ACP-ASIM Position Paper – Peter Zed, Peter Loewen

Reader Responses to this Editorial

Do you have an opinion about ACP-ASIM Position paper?  Let us know what you think!

Peer-Reviewed Research Articles – original scholarly contributions

Evidence-Based Reviews of the Pharmacotherapeutic Literature with emphasis on interpretation of the findings, designed to help practitioners put the findings into proper perspective

Issues in Pharmacotherapy Practice contemporary issues by clinical practitioners

Research Abstracts rapid dissemination of research findings

Pharmacotherapy on the Web helping pharmacotherapy practitioners use the web to enhance their practice

Technology in Practice Section (TIPS)

“Our Age of Anxiety is, in great part, the result of trying to do today’s jobs with yesterday’s tools.” These words of the distinguished communications theorist Marshall McLuhan were never more true. Today’s health practitioners are constantly challenged by the increasing volume of health information, the changing technology skills required, and avoiding both information overload and anxiety. Pharmacotherapy practitioners require a core level of technology competence in order to keep pace with patient needs in today’s health systems. A lack of technology skills might lead to anxiety, information overload and sub optimal patient care.

We are agree with a January 2001 editorial which states that pharmacists have not been at the forefront of integrating available technologies into their practice settings and that there is a “worrisome” technology gap in our profession.  A survey we conducted at our institution in May 2001 indicated that the greatest work-related technology challenge that pharmacists perceived was a lack of skills required to effectively use currently available technology and on-line resources for patient care. The vast majority of the respondents believed that their practice effectiveness would significantly increase if their computer, Internet, and information management skills could be improved.

The purpose of the TIPS is to empower readers with the knowledge required to integrate technology into their practice to improve patient care, research, education and life-long learning effectiveness. The section of the JIP will focus on technologies that are currently available, ubiquitous and can be procured “off-the-shelf” by individuals. The TIPS will expand the scope of the “Pharmacotherapy on the Web” section, which has been part of the JIP since its inception. Web site reviews will expand to include resources that provide content on information management and computer skills.

We invite readers to guide the subject matter of the TIPS section by submitting questions and topic suggestions. We are interested in hearing about what your technology related challenges are and hope to provide a forum for addressing some of the questions you have. Also, we invite you to submit a description of the innovative solutions that you have developed to meet some of these challenges in your practice setting.

The TIPS section of the JIP will feature topics such as:

  • How to use the Internet to help you keep up with the literature and improve your practice
  • How to choose and use a personal digital assistant (PDA) for you practice
  • Critical evaluations of drug and disease information software
  • How to manage and organize your professional resource material
  • How to make your pertinent resources electronically available to you in your practice area
  • Methods for optimizing internet and medical database search strategies
  • Regaining control of your email in-box
  • Forums for reader-initiated information exchange
  • Knowledge management and knowledge sharing in practice

We look forward to your questions and hearing about your day-to-day technology-related challenges.

Submit your Favorite Site!

  • HealthySkepticism.org
  • Health Protection Branch Drug Advisories

Reader Service – Incorrect Text

In the Original Research article entitled “Stability of Domperidone in Extemporaneously Compounded Suspensions” published in The Journal of Informed Pharmacotherapy 2002;8:100-104 an error had occurred regarding the domperidone product used in the study.  Under the Methods section, subsection Preparation and Evaluation of Suspension, the first sentence should read “Domperidone suspensions (1 and 10 mg/mL) were prepared in triplicate from commercially-available tablets of domperidone maleate (Novo-domperidone®, Novopharm, Scarborough, Ontario), containing domperidone 10 mg per tablet, and mixed with equal parts of Ora-Sweet® and Ora-Plus® (Paddock Laboratories Inc., Minneapolis, MN, lots OE6324 and OH6525, respectively).”

Latest Posts